Medicare Enrolled
Dr. Meera Shreedhara Vasudha, MD
Hematology & Oncology · Greenville, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shreedhara Vasudha from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shreedhara Vasudha?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shreedhara Vasudha
Dr. Meera Shreedhara Vasudha is a hematology & oncology specialist in Greenville, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Shreedhara Vasudha performed 123,889 Medicare services across 1,988 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shreedhara Vasudha received a total of $1,827 from 22 pharmaceutical and/or device companies across 42 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shreedhara Vasudha is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 5% volume in TX
$1,827 industry payments
Medicare Practice Summary
Medicare Utilization ↗123,889
Medicare services
Top 5% in TX for hematology & oncology
1,988
Unique beneficiaries
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~6,883 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
51,400 | $0 | $2 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
23,705 | $2 | $20 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
21,750 | $0 | $5 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
14,100 | $0 | $2 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,525 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,030 | $1 | $114 |
| Injection, granisetron hydrochloride, 100 mcg | 900 | $0 | $24 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
659 | $2 | $13 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
653 | $90 | $368 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
559 | $12 | $108 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
358 | $98 | $707 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
323 | $11 | $96 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
319 | $2 | $300 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
296 | $47 | $313 |
| Injection, potassium chloride, per 2 meq | 285 | $0 | $1 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
284 | $22 | $157 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
259 | $55 | $250 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
231 | $54 | $211 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
229 | $6 | $431 |
| Anti-nausea injection (ondansetron/Zofran) | 224 | $0 | $4 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
176 | $21 | $161 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
156 | $131 | $496 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
148 | $1 | $7 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
121 | $48 | $344 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 114 | $136 | $3,675 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
110 | $2 | $19 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
93 | $31 | $150 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
88 | $1 | $8 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
88 | $72 | $70 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
67 | $123 | $500 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
65 | $110 | $565 |
| New patient office visit, complex (60-74 min) | 64 | $159 | $709 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
61 | $41 | $289 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
61 | $19 | $114 |
| Intravenous chemotherapy injection Chemotherapy medication is administered directly into a vein using a push technique. This method involves injecting the drug through a needle or catheter already placed in the vein. |
52 | $76 | $500 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
51 | $74 | $372 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
48 | $28 | $247 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
48 | $26 | $145 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
38 | $10 | $75 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
37 | $25 | $256 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
37 | $57 | $231 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
25 | $56 | $264 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
22 | $1 | $19 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
19 | $34 | $143 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
11 | $30 | $58 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.0% high complexity
97.5% medium
1.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,827
Total received (2018-2024)
Avg $305/year across 6 years
Bottom 38% in TX for hematology & oncology
22
Companies
42
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Other
Charitable contributions, space rental, and other categories
$1,098 (60.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$521 (28.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$208 (11.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$251
2023
$307
2022
$450
2021
$658
2019
$145
2018
$16
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$970
NOVARTIS PHARMACEUTICALS CORPORATION
$167
Pharmacyclics LLC, An AbbVie Company
$99
SANOFI-AVENTIS U.S. LLC
$85
Merck Sharp & Dohme LLC
$64
GENZYME CORPORATION
$51
GlaxoSmithKline, LLC.
$48
Takeda Pharmaceuticals U.S.A., Inc.
$38
Incyte Corporation
$37
Gilead Sciences, Inc.
$33
Kite Pharma, Inc.
$31
E.R. Squibb & Sons, L.L.C.
$23
Genentech USA, Inc.
$23
Spectrum Pharmaceuticals Inc.
$23
SOBI, INC
$22
ARRAY BIOPHARMA INC
$21
AstraZeneca Pharmaceuticals LP
$20
Lilly USA, LLC
$19
Amgen Inc.
$17
TESARO, Inc.
$16
Acrotech Biopharma LLC
$12
PFIZER INC.
$11
Top 3 companies account for 67.6% of total payments
Associated products mentioned in payments ›
AFINITOR · BELEODAQ · DOPTELET · ELITEK · EMPLICITI · ENHERTU · FRUZAQLA · IBRANCE · Imbruvica · Itovebi · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · LUMAKRAS · LUTATHERA · OJJAARA · OPDIVO · ROLVEDON · SARCLISA · SCEMBLIX · VERZENIO · XALKORI · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Payments are distributed across multiple categories with no single dominant type.
Equivalent to $1 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
1
Per 100K population
1.0
County median income
$70,112
Nearest hospital
HUNT REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Shreedhara Vasudha is a mixed practice specialist, with above-average Medicare volume (top 5% in TX), with mixed engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Shreedhara Vasudha experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Shreedhara Vasudha performed 51,400 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shreedhara Vasudha receive payments from pharmaceutical companies?
Yes. Dr. Shreedhara Vasudha received a total of $1,827 from 22 companies across 42 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shreedhara Vasudha's costs compare to other hematology & oncology specialists in Greenville?
Dr. Shreedhara Vasudha's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shreedhara Vasudha) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Greenville
Browse hematology & oncology specialists in Greenville ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
NOVARTIS PHARMACEUTICALS CORPORATION Payments to Doctors
See all physicians who received payments from NOVARTIS PHARMACEUTICALS CORPORATION.
By company
Pharmacyclics LLC, An AbbVie Company Payments to Doctors
See all physicians who received payments from Pharmacyclics LLC, An AbbVie Company.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology